Heart Failure

Heart Failure - 2017 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/244042

Contents of this Issue

Navigation

Page 16 of 61

17 Stage C Nonpharmacological Interventions Education Î Patients with HF should receive specific education to facilitate HF self-care. (I-B) Sodium Restriction Î Sodium restriction is reasonable for patients with symptomatic HF to reduce congestive symptoms. (IIa-C) Sleep Disorders Î Refer to Table 33 below. Activity, Exercise Prescription, and Cardiac Rehabilitation Î Exercise training (or regular physical activity) is recommended as safe and effective for patients with HF who are able to participate to improve functional status. (I-A) Î Cardiac rehabilitation can be useful in clinically stable patients with HF to improve functional capacity, exercise duration, health-related quality of life (HRQOL), and mortality. (IIa-B) Pharmacological Treatment for Stage C HFrEF (see Figure 2, Table 12 and Table 13) Î Measures listed as Class I recommendations for patients in stages A and B are recommended where appropriate for patients in stage C. (I-A, I-B, and I-C as appropriate) Î GDMT as depicted in Figure 1 should be the mainstay of pharmacological therapy for HFr EF. (I-A)

Articles in this issue

view archives of Heart Failure - Heart Failure - 2017 Update